LEC appoints Alison Squire
March 18, 2010Medical Communications LEC, Lane Earl Cox, appointment, medical communications
Lane Earl Cox has appointed Alison Squire as international account director.She joins the advertising agency from HC&B Healthcare and has …
Genzyme plays down Irish contamination
March 18, 2010Manufacturing and Production Cerezyme, Contamination, Fabrazyme, Genzyme
The contamination problems plaguing Genzyme in the US have also appeared in product manufactured at its plant in Waterford, Ireland, …
Tekturna fails to show heart attack benefit
March 17, 2010Research and Development Diovan, Novartis, Tekturna, hypertension
Novartis’ hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard …
UK to get biotech academy
March 17, 2010Business Services biotech, pharma training, skills
A national biotech academy will be set up in the UK as part of a government plan to ensure that …
Study boost for atrial fibrillation drugs
March 17, 2010Research and Development Pradaxa, VTE, Xarelto, apixaban, betrixaban
Two rival drugs have both shown benefits over warfarin in patients with atrial fibrillation, according to new research. Boehringer Ingelheim’s …
Shipra Singh joins Porter Novelli
March 17, 2010Medical Communications Porter Novelli, appointment, medical communications
Porter Novelli has appointed Shipra Singh as head of healthcare for Europe, the Middle East and Africa. She was most …
WuXi’s growth slows
March 17, 2010Research and Development CRO, China, WuXi
WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …
FDA questions delay long-acting Byetta
March 17, 2010Manufacturing and Production Bydureon, Byetta, Syncria, Victoza
A once-weekly formulation of Eli Lilly and Amylin Pharmaceuticals’ blockbuster diabetes medication Byetta has hit a manufacturing hurdle en route …
Bill Burns joins Shire board
March 17, 2010Research and Development, Sales and Marketing Shire, appointment, research and development, sales and marketing
Former Roche pharma chief executive Bill Burns has joined the board at Shire as a non-executive director. Burns has also …
Digital Pharma: Merck Serono expands PKU website
March 16, 2010Medical Communications Kuvan, Merck Serono, PKU
Merck Serono has expanded its European phenylketonuria disease awareness website, adding versions in French and Spanish. The website was originally …
Lilly acquires rights to testosterone treatment
March 16, 2010Sales and Marketing Acrux, hormone, lilly, male health
Lilly have entered into a worldwide licensing agreement with Australian-based Acrux for Axiron, an experimental under-arm testosterone applicator.The treatment is …
OSI resists Astellas and invites other offers
March 16, 2010Sales and Marketing Astellas, OSI, merger
A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …
Conventional hypertension prescribing ‘should be reconsidered’
March 16, 2010NICE, hypertension
New findings throwing doubt on conventional wisdom about high blood pressure may have implications for NICE’s advice on hypertension. Published …
Edinburgh BioQuarter appoints commercialisation director
March 16, 2010Research and Development Edinburgh BioQuarter, appointment, research and development
Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation. He will lead a …
CME Spotlight: The numbers game
March 16, 2010Medical Communications CME, CME Spotlight
We live in a world where people seem to have developed a strange obsession with numbers.I am still baffled at …
Revolade gets European go ahead
March 15, 2010Sales and Marketing GlaxoSmithKline, Revolade, thrombocytopenia
European regulators have approved GlaxoSmithKline’s Revolade to treat reduced platelet count in patients with a rare blood disorder. Revolade (eltrombopag) …
FDA strengthens Plavix safety warning
March 15, 2010Sales and Marketing Plavix
A boxed warning has been added to the US packaging of Sanofi-Aventis and Bristol-Myers Squibb’s blockbuster anti-clotting drug Plavix. The …
GSK promotes Jean Stephenne to chairman, biologicals
March 15, 2010Research and Development, Sales and Marketing GlaxoSmithKline, appointment, research and development, sales and marketing
GlaxoSmithKline has appointed Jean Stephenne chairman of GSK Biologicals, the company’s global vaccines division.He is currently president and general manager of …
Contract research news in brief
March 15, 2010Research and Development Bilcare, CRO, Kendle, Lonza, Medidata, Melbourn, Quintiles, RDNIB
Our round-up of developments in the contract research sector includes updates from Kendle, Bilcare, Quintiles, Melbourn Scientific, Lonza, and Medidata …
Paul Holmes rejoins PM Society
March 12, 2010Medical Communications PM Soc, appointment, medical communications, pm society
The Pharmaceutical Marketing Society has appointed Paul Holmes business development director. He will also rejoin the Society as a committee …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
